QC
VANI icon

Quadrature Capital’s Vivani Medical VANI Stock Holding History

Quadrature Capital’s Portfolio VANI Stock Details VANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,333
Closed -$23.8K – 1883
2025
Q4 		$23.8K Buy
+19,333
New +$27.9K ﹤0.01% 1203

Other funds holding VANI

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TWM
Tanager Wealth Management Goring On Thames, United Kingdom $1.03B AUM 16.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Quadrature Capital's VANI Position: Q1 2026 in Review

Quadrature Capital sold out of Vivani Medical (VANI) in Q1 2026, closing a stake of 19,333 shares — an estimated $23.8K sold.

Quadrature Capital first reported a position in VANI in Q4 2025 and held it in 1 quarter. The position peaked at $23.8K in Q4 2025. 43 funds tracked by Wall St. Rank hold VANI as of Q1 2026.

  • Quadrature Capital reported no remaining Vivani Medical position as of Q1 2026 after selling out during the quarter.
  • Quadrature Capital sold 19,333 Vivani Medical shares in Q1 2026, an estimated $23.8K.
  • Quadrature Capital first reported a position in Vivani Medical in Q4 2025 and held it in 1 quarter.
  • Quadrature Capital's Vivani Medical position peaked at $23.8K in Q4 2025.
  • 43 funds tracked by Wall St. Rank held Vivani Medical as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.